HEPCASIA HEPCASIA HEPCASIA
Navigation
  • Home
  • Advocating for Access
    • Background
    • Letters for Access
    • Press Releases For Access
  • Simplified Community Materials
    • Simplified Community Materials
    • Understanding your HCV infection
    • Community Led Reports
    • Country Information
      • Indonesia
      • India
      • Vietnam
  • Generic DAAs Pricing
  • Resources
    • Guidelines
    • Key Research Publication
    • Other Important Documents and Reports
  • News
  • Gallery
    • Photos
    • Video
  • Stories

New WHO guideline on care and treatment of chronic hepatitis C

WHO published guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection. For those who need more in-depth information on chronic hepatitis C treatment, this guideline can be useful. You can download from Resources under sub heading Guidelines or you can directly download from the link ……..Guidelines for the Care and Treatment of persons diagnosed with chronic hepatitis C virus infections

August 14, 2018 / News

Related Posts

Community group taking actions to enable greater access for generic HCV treatment
Glecaprevir-Pibrentasvir Effective for Hepatitis C After Treatment Failure
IAC a community group in Indonesia demanding national food and drugs authority to expedite registration process of DAA medicines in Indonesia
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Hepatitis C Treatment Snapshots: Daclatasvir
Part 1: What is hepatitis C and how is it diagnosed?
Patent Situation of The Key Product for Treatment of Hepatitis C: DACLASTAVIR – WHO working paper, revised version, Oct 2014
Part 2: How is hepatitis C treated?

About Us

hepcasia.com is managed by Asia Pacific Network of People Living with HIV (APN+), is dedicated to the work conducted by the community and civil society in Asia to highlight the epidemic in various fora. This is also intended to serve as a source of information, resource and materials that can be used to advocate for treatment access at national and other levels.

Latest Tweet

#hepatitis #HepCtreatment Latest generic Indian Daclatasvir pricing @HepCAsia

#hepatitis #HepCtreatment snapshot Ledipasvir + Sofosbuvir co-formulation

#HepCtreatment snapshot @HepCAsia

Follow Us @HepCAsia
Hepatitis C in Asia - 2023